US Bankruptcy Court gave an order approving the sale of the substantially all the assets related to Biossance brand on December 12, 2023. The debtor has been authorized to sell substantially all Biossance brand?s assets to MenoLabs Brand Assets, the winning bidder at the auction, for a purchase price of $3 million. Under the terms of the asset purchase agreement, the buyer has made an earnest money deposit of $0.03 million upon the execution of the agreement.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.002 USD | 0.00% | -60.00% | -20.00% |
May. 07 | Han Kieftenbeld to leave as Chief Financial Officer of Amyris, Inc | CI |
May. 07 | Kathy L. Fortmann to Join Amyris, Inc. as Member of the Board of Directors | CI |
1st Jan change | Capi. | |
---|---|---|
-20.00% | 745K | |
+1.61% | 49.2B | |
+16.33% | 41.24B | |
+18.68% | 25.89B | |
+12.78% | 19.81B | |
+0.85% | 17.48B | |
-21.87% | 15.86B | |
+2.32% | 15.35B | |
-10.29% | 15.23B | |
-22.30% | 13.36B |
- Stock Market
- Equities
- AMRS Stock
- News Amyris, Inc.
- Motion for Asset Sale Approved for Amyris, Inc.